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T he potential of in vivo gene therapy and DNA immunization depends upon the development of safe, effective, and economic delivery systems that meet with clinical and patient acceptance. Although there are many systems of DNA delivery into cell, the major disadvantage is their limited clinical utility because of complex and expensive manipulation. With clinical applications in mind, especially for most surgical operation, we tested the effectiveness of surgical suture that is more clinic related, more patient friendly, and more versatile than other delivery methods. To evaluate the potential effectiveness of this approach in human, we used the commonly used surgical suture for DNA delivery into rabbit models first in this study. Overall, we sought to evaluate the effects of gene delivery by means of surgical suture, in light of potential medical applications for gene therapy and DNA vaccinations.
Materials and Methods

Plasmids construction
For the construction of pBLacZ, a Hind III-Sst I fragment from the lacZ expression clone was served as the vector. This fragment contained the plasmid sequences for propagation of the clone in E.coli, the SV40 early-region promoter as well as the 3' end of lacZ followed by the SV40 polyadenylation signal. Downstream from the SV40 promoter carries a HindIII-NcoI fragment carrying the 5' untranslated region including the eukaryotic ATG start codon that is contained in the NcoI-site. In frame with the start codon, lacZ coding sequences were inserted from the Lac Z expression cassette. Both plasmids were prepared using standard procedures.
Molecular surgical suture preparation for gene transfer
The purified pBLacZ plasmid (OD260/OD280= 1.9) was dissolved in PBS buffer with 5% sucrose (pH=7.4) and the final concentration was 1 µg/L. Surgical suture of 1 cm length was specifically selected.The molecular surgical suture was prepared by soaking suture into the above solution (experimental group) and the PBS solution (control group) overnight and then air dried until the needed amount of plasmids were thoroughly absorbed.
Animal model
New Zealand white rabbits were used for all experiments. The rabbits (mean weight, 3 kg) were anesthetized with ketamine (50 mg/kg) and xylazine (5 mg/kg). Muscle regeneration was induced by injection of 500 µL of 0.5% bupivacaine solution 3 days before plasmid delivery. All rabbits were humanely euthanized by CO2 asphyxiation at the end of the experiments. These studies were approved by the Institutional Animal Care and Use Committees (IACUC) and performed in accordance with the Guide for the Care and Use of Laboratory Animals.
Intramuscular gene transfer
5-0 thread was introduced into the anterior tongue of rabbit and the whole tongue was extracted by pulling out of the oral cavity. An incision was cut with a length of 1.5 cm and a depth of 1 cm along the lateral of tongue, where blood supply was ample and a surgical assistant was necessary for hemostasis. Intramuscular gene delivery was performed by placing the molecular surgical suture into the incision along the longitudinal axis of the muscle and parallel to the muscle fibers as soon as possible.The incision was quickly closed and marked with a ligature at each end of it. A control piece of muscle was also marked at an area far from this incision site.To keep variability to a minimum, the same skilled operator and assistant performed all procedure after training. The frequence of surgical transfer failure is zero.
In vivo β β-galactosidase histochemistry assay
Rabbits were sacrificed on the 7 th , 30 th days after transfection of lacZ gene.The biopsy of tongue muscle containing the molecular surgical suture between two marking ligatures was removed with a small sharp surgical knife so that the long axis of the strip was parallel to the long axis of the muscle fiber and embedded surgical suture. A control piece of muscle was removed at an area far from this incision site. The serial sections (5 µm) made with a cryostat microtome were placed immediately on gelatinized slides. The sections were fixed with 1.25% glutaraldehyde for 10 min, then rinsed three times with PBS, and incubated with X-gal staining solution at 37°C for 48 hours. After incubation, sections were rinsed with PBS and then cleared in increasing concentrations of alcohol and xylene, and mounted with coverslips in mounting medium.
RT-PCR
Total RNA from transfected muscles and control tissues was extracted with TRIZOL reagent (Gibco-BRL, NY, USA) following the manufacturer's instruction. The RNA was reverse-transcribed using the SuperScriptTM Preamplification System (Gibco-BRL, MD, USA), and the resulting cDNA was amplified by PCR using Taq DNA polymerase (Takara Shuzou, Shiga, Japan) and the specific primers for LacZ. The following oligonucleotides were used as primers for PCR: the LacZ sense primer 5-CAATCCCCTGTGGAGGCTCCA-3 and the anti-sense primer 5-GACCAAGTCGTCAC-CTCGCAG-3. Samples were subjected to 28 cycles of 1 min of denaturation at 94°C, 1 min of annealing at 61°C and 1 min of synthesis at 72°C.The gene expression level of RT-PCR bands was measured by densitometer.
Results
Expression of β-galactosidase protein
β-galactosidase as marker enzyme provides the advantage that the location of expressed foreign DNA can be readily determined. Expression of β-galactosidase protein in the myofibers of tongue muscle was observed in the vicinity of the suture seven days and one month after the gene transfer, no control muscle contained any positive myofibers (Figure 1 ). These results indicate that non-human rodent myofibers have the ability to uptake and express the pasmid DNA by molecular surgical suture.
Expression of β-galactosidase mRNA β-galactosidase mRNA was positive in PBLacZ transfected tongue muscle one week and one month after gene transfer by molecular surgical suture. RT-PCR for β-galactosidase mRNA in control group was negative (Figure 2 ).
Discussion
In this study, we investigated the pattern of plasmid DNA transfer by surgical suture that are suit-able for clinical applications.We also showed, for the first time, the effectiveness of DNA delivery into tongue muscle on rabbits by surgical suture, which might give suggestion of potential applicability of this method on human gene therapy and DNA vaccination.
The new technique for gene transfer in vivo described in this report conforms to the method used clinically and is compatible with the most clinical surgical operation procedures. In this regard, effective gene can be clinically incubated in surgical area by surgical suture during operation procedure because we must handle with muscles in most of surgical operations. As a delivery system, the absorbable cotton suture might act not only as gene carrier, but also as an adjuvant that could produce a cushioning effect on the uptake of high doses of plasmid through slow release of the absorbed plasmid DNA into the interstitial space (Labhasetwar, 1998) . Thus it prevented the rapid degradation of DNA following injection and promoted their access to myofibers. In this report, tongue muscles are composed of large skeletal muscle fiber cells containing hundreds of postmitotic myonuclei, which might account for the high efficiency of plamid DNA uptake although the mechanisms are not precisely known. This interpretation is supported by histological and RT-PCR evidences showing that lacZ expression indeed takes place primarily in the muscle layer under the experimental conditions used.
As far as the biosafety of the current method is concerned, no signs of adverse effects or irreversible alteration of function were detected during our experiment, and no impairment of skin, hair, necrosis were observed in any of the rabbits. However, tongue edema was observed in the animals after gene transfer, and the edema diminished in a couple of days. In one pre-experimental rabbit, tongue edema was so massive that the animal had to be sacrificed 9 days after the gene transfer. This kind of abnormality was no longer observed in the other experimental animals. Some recent researches have provided encouraging human immune response data in support of this plasmid DNA transfer technology (Conry, 2002 , Huang, 2001 ). The next step should be the clinical assessment of the safety and efficacy of plasmid DNA delivery with gene transfer suture if possible.
The findings of the current study are likely to provide a useful gene transfer approach that may be applicable to the surgical procedures for human gene therapy. Further study should be made to solve the problem of efficiency of gene expression (Niidome, 2002) . It has been reported that electroporation methods significantly enhance direct injection of naked DNA (Martin, 2000) and in vivo transfection methods with antisense oligonucleotides and small interfering RNA (siRNA) showed greatly increased efficiency of naked DNA gene transfer. (Herweije, 2003) . Combined with these new advance and clinical cancer related gene (Dan,2003) , our molecular surgical suture technology will make naked DNA gene transfer a viable method for gene therapy in the near future.
